Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Human Metabolome Technologies Inc lowers consolidated full-year outlook for FY 2014


Monday, 28 Apr 2014 02:00am EDT 

Human Metabolome Technologies Inc:Lowered the consolidated full-year outlook for revenue to 610 million yen from 638 million yen for the fiscal year ended March 2014.Sees a decrease of operating profit forecast to a loss of 12 million yen from 10 million yen.Sees a decrease of ordinary profit forecast to 5 million yen from 26 million yen.Sees a decrease of net profit forecast to 1 million yen from 23 million yen.Sees a decrease of earnings per share to 0.38 yen from 5.47 yen.Comments the reduced order, the increased cost due to increased staff, the selling expenses and the management cost are the main reasons for the forecast.